Northwest Biotherapeutics NWBO
OTC NWBO
$0.15 -0.01 (-6.25%)
At close: Sep 28, 2026 · 4:00 PM EDT

Northwest Biotherapeutics (NWBO) FCF Margin (2010 - 2026)

Updated

Northwest Biotherapeutics (NWBO) posted FCF Margin of -912.89% for Q2 2026, up 4424.52 percentage points from -5337.40% a year earlier and up 1645.41 percentage points from the prior quarter.

Analysis

Northwest Biotherapeutics (NWBO) FCF Margin (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, FCF Margin at Northwest Biotherapeutics was -2290.34%, up 1838.64 percentage points year-over-year; for FY2025, it was -3357.55%, up 841.51 percentage points from FY2024.

  • Annual FCF Margin shows a five-year change of -359.64 percentage points (FY2020 to FY2025).
  • In prior years, Northwest Biotherapeutics' FCF Margin was -4199.06% in FY2024 (-1244.92 pp), -2954.14% in FY2023 (+354.06 pp), -3308.20% in FY2022 (+1101.15 pp) and -4409.35% in FY2021 (-1411.44 pp).
  • The Q2 2026 figure stands as the highest quarterly FCF Margin since Q4 2019.
  • On a year-over-year basis, FCF Margin increased in four of the last eight quarters, with an average year-over-year change of +290.10 percentage points.
  • The strongest year-over-year quarter for FCF Margin in the past five years was Q4 2025, with a gain of 6438.43 percentage points; the weakest was Q3 2022, with a drop of 5185.68 percentage points.
  • According to Business Quant data, FCF Margin for the three prior quarters was -2558.30% (Q1 2026), -2331.70% (Q4 2025) and -7047.50% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.82%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 18.33%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 26.96%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 43.05%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 34.72%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.70%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 30.39%
10 Northwest Biotherapeutics 250.40 Mn 240.41 Mn - -912.89%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -912.89%
Mar 31, 2026 -2,558.30%
Dec 31, 2025 -2,331.70%
Sep 30, 2025 -7,047.50%
Jun 30, 2025 -5,337.40%
Mar 31, 2025 -2,536.27%
Dec 31, 2024 -8,770.13%
Sep 30, 2024 -2,355.46%
Jun 30, 2024 -3,278.04%
Mar 31, 2024 -4,452.46%
Dec 31, 2023 -3,904.72%
Sep 30, 2023 -3,535.96%
Jun 30, 2023 -6,353.23%
Mar 31, 2023 -1,428.64%
Dec 31, 2022 -1,844.05%
Sep 30, 2022 -7,958.25%
Jun 30, 2022 -3,196.86%
Mar 31, 2022 -3,232.01%
Sep 30, 2021 -2,772.57%
Jun 30, 2021 -1,994.95%
API Access

Northwest Biotherapeutics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=NWBO&period=max&api_key=YOUR_API_KEY